(Q37864387)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Environmental triggers of multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Kristina Kakalacheva

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

7 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

3724-3729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486562%20AND%20SRC:MED&resulttype=core&format=json

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

The type I diabetes association of the IL2RA locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Delineating the genetic basis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

21 January 2018

Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

The causal cascade to multiple sclerosis: a model for MS pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Epstein-Barr virus in pediatric multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Selective association of multiple sclerosis with infectious mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Epstein-Barr virus: exploiting the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Detection of human herpesviruses 6 and 7 genomic sequences in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Can infections protect against autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Association between parasite infection and immune responses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Helminths and multiple sclerosis: will old friends give us new treatments for MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Immunomodulatory actions of 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Regional variations in the prevalence of multiple sclerosis in French farmers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Distribution and mortality time trend of multiple sclerosis and some other diseases in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Monthly ambient sunlight, infections and relapse rates in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Smoking and multiple sclerosis: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Smoking, use of moist snuff, and risk of chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Multiple Sclerosis After Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006

Sun exposure and vitamin D are independent risk factors for CNS demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.04.006